Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2025-07-23 00:00:00 ET · period of report 2025-07-21 · accession 0001104659-25-070013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-23 | 2025-07-21 | SGMT | Rozek Elizabeth | GC, CCO | S - Sale | $9.13 | -10.8K | 183.7K | -6% | -$98.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2025-07-21 | S | D | 10,780 | $9.13 | 183,726 | D | — | — |